Cargando…

Circulating miR-21 as a prognostic biomarker in HCC treated by CT-guided high-dose rate brachytherapy

BACKGROUND AND AIMS: Prognostic biomarkers identifying patients with early tumor progression after local ablative therapy remain an unmet clinical need. The aim of this study was to investigate circulating miR-21 and miR-210 levels as prognostic biomarkers of HCC treated by CT-guided high-dose rate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stechele, Matthias, Link, Henrike, Hirner-Eppeneder, Heidrun, Alunni-Fabbroni, Marianna, Wildgruber, Moritz, Salvermoser, Lukas, Corradini, Stefanie, Schinner, Regina, Ben Khaled, Najib, Rössler, Daniel, Galun, Eithan, Goldberg, Shraga Nahum, Ricke, Jens, Kazmierczak, Philipp Maximilian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10375621/ https://www.ncbi.nlm.nih.gov/pubmed/37507808 http://dx.doi.org/10.1186/s13014-023-02316-2

Ejemplares similares

Post-therapeutic microRNA-146a in liquid biopsies may determine prognosis in metastatic gastrointestinal cancer patients receiving (90)Y-radioembolization
por: Hirner-Eppeneder, Heidrun, et al.
Publicado: (2023)

Peripheral blood-based cell signature indicates response to interstitial brachytherapy in primary liver cancer
por: Kästle, Sophia, et al.
Publicado: (2023)

Early monocyte response following local ablation in hepatocellular carcinoma
por: Kimm, Melanie A., et al.
Publicado: (2022)

Fibroblast growth factors induce hepatic tumorigenesis post radiofrequency ablation
por: Markezana, Aurelia, et al.
Publicado: (2023)

Tumor-Associated Macrophages—Implications for Molecular Oncology and Imaging
por: Kimm, Melanie A., et al.
Publicado: (2021)

NMR-Based Lipid Metabolite Profiles to Predict Outcomes in Patients Undergoing Interventional Therapy for a Hepatocellular Carcinoma (HCC): A Substudy of the SORAMIC Trial
por: Geyer, Thomas, et al.
Publicado: (2021)

Circulating Cell-Free DNA Combined to Magnetic Resonance Imaging for Early Detection of HCC in Patients with Liver Cirrhosis
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2021)

A Multi-Scale and Multi-Technique Approach for the Characterization of the Effects of Spatially Fractionated X-ray Radiation Therapies in a Preclinical Model
por: Romano, Mariele, et al.
Publicado: (2021)

Integrin-targeted quantitative optoacoustic imaging with MRI correlation for monitoring a BRAF/MEK inhibitor combination therapy in a murine model of human melanoma
por: Kazmierczak, Philipp M., et al.
Publicado: (2018)

HDR Brachytherapy and SBRT as Bridging Therapy to Liver Transplantation in HCC Patients: A Single-Center Experience
por: Walter, Franziska, et al.
Publicado: (2021)

Monitoring Cell Death in Regorafenib-Treated Experimental Colon Carcinomas Using Annexin-Based Optical Fluorescence Imaging Validated by Perfusion MRI
por: Kazmierczak, Philipp M., et al.
Publicado: (2015)

(18)F–FDG-PET/CT and diffusion-weighted MRI for monitoring a BRAF and CDK 4/6 inhibitor combination therapy in a murine model of human melanoma
por: Eschbach, Ralf S., et al.
Publicado: (2018)

Extracellular Vesicles May Predict Response to Radioembolization and Sorafenib Treatment in Advanced Hepatocellular Carcinoma: An Exploratory Analysis from the SORAMIC Trial
por: Shuen, Timothy Wai Ho, et al.
Publicado: (2022)

Myofibroblasts: A key promoter of tumorigenesis following radiofrequency tumor ablation
por: Moussa, Marwan, et al.
Publicado: (2022)

Contrast-Enhanced Ultrasound with VEGFR2-Targeted Microbubbles for Monitoring Regorafenib Therapy Effects in Experimental Colorectal Adenocarcinomas in Rats with DCE-MRI and Immunohistochemical Validation
por: Eschbach, Ralf Stefan, et al.
Publicado: (2017)

Early-Stage HCC Percutaneous Locoregional Management: East versus West Perspectives
por: Iezzi, Roberto, et al.
Publicado: (2023)

(68)Ga-TRAP-(RGD)(3) Hybrid Imaging for the In Vivo Monitoring of α(v)ß(3)-Integrin Expression as Biomarker of Anti-Angiogenic Therapy Effects in Experimental Breast Cancer
por: Kazmierczak, Philipp M., et al.
Publicado: (2016)

Evaluation of D-TACE combined with endovascular brachytherapy for HCC with MPVTT
por: Huang, Wei, et al.
Publicado: (2022)

Systemic siRNA Nanoparticle-Based Drugs Combined with Radiofrequency Ablation for Cancer Therapy
por: Ahmed, Muneeb, et al.
Publicado: (2015)

Increased MicroRNA Activity in Human Cancers
por: Israel, Ariel, et al.
Publicado: (2009)

The two facets of gp130 signalling in liver tumorigenesis
por: Schmidt-Arras, Dirk, et al.
Publicado: (2021)

DNA damage alters EGFR signaling and reprograms cellular response via Mre-11
por: Volman, Yael, et al.
Publicado: (2022)

Interstitial High-Dose-Rate Brachytherapy of Liver Metastases in Oligometastatic Patients
por: Walter, Franziska, et al.
Publicado: (2021)

Correlation of Perfusion MRI and (18)F-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation
por: Eschbach, Ralf S., et al.
Publicado: (2015)

Lymphadenopathy Associated With the COVID-19 Vaccine
por: Hiller, Nurith, et al.
Publicado: (2021)

Prognostic value of baseline interleukin 6 levels in liver decompensation and survival in HCC patients undergoing radioembolization
por: Öcal, Osman, et al.
Publicado: (2021)

The dosimetric impact of replacing the TG-43 algorithm by model based dose calculation for liver brachytherapy
por: Duque, Anna Sophie, et al.
Publicado: (2020)

Tumor-suppressive effect of S-adenosylmethionine supplementation in a murine model of inflammation-mediated hepatocarcinogenesis is dependent on treatment longevity
por: Stoyanov, Evgeniy, et al.
Publicado: (2017)

Measuring HCC Tumor Size in MRI—The Sequence Matters!
por: Armbruster, Marco, et al.
Publicado: (2021)

Comparison of liver exposure in CT-guided high-dose rate (HDR) interstitial brachytherapy versus SBRT in hepatocellular carcinoma
por: Walter, Franziska, et al.
Publicado: (2021)

Extended Postinterventional Tumor Necrosis—Implication for Outcome in Liver Transplant Patients with Advanced HCC
por: Kornberg, Arno, et al.
Publicado: (2013)

A(3 )adenosine receptors and mitogen-activated protein kinases in lung injury following in vivo reperfusion
por: Matot, Idit, et al.
Publicado: (2006)

Characterization and Evaluation of Injectable Biodegradable Polymer Multimodality Radiologic Markers in an In Vivo Murine Model
por: Ben-David, Eliel, et al.
Publicado: (2022)

Characterization and prognosis of patients with hepatocellular carcinoma (HCC) in the non-cirrhotic liver
por: Schütte, Kerstin, et al.
Publicado: (2014)

Identification of a novel peptide targeting TIGIT to evaluate immunomodulation of (125)I seed brachytherapy in HCC by near-infrared fluorescence
por: Zeng, Peng, et al.
Publicado: (2023)

Impact of adjuvant sorafenib treatment after local ablation for HCC in the phase II SORAMIC trial
por: Seidensticker, Max, et al.
Publicado: (2023)

An NTCP Analysis of Urethral Complications from Low Doserate Mono- and Bi-Radionuclide Brachytherapy
por: Nuttens, V. E., et al.
Publicado: (2011)

Semi-Automatic MRI Feature Assessment in Small- and Medium-Volume Benign Prostatic Hyperplasia after Prostatic Artery Embolization
por: Schmidt, Vanessa F., et al.
Publicado: (2022)

Circulating DNA as prognostic biomarker in patients with advanced hepatocellular carcinoma: a translational exploratory study from the SORAMIC trial
por: Alunni-Fabbroni, Marianna, et al.
Publicado: (2019)

Image-guided high-dose-rate brachytherapy of malignancies in various inner organs – technique, indications, and perspectives
por: Bretschneider, Tina, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_t4amfh28rnopka3i0c50om9m5q